THE PENNANT GROUP, INC. Selling, General and Administrative Expense
THE PENNANT GROUP, INC. (PNTG) reported Selling, General and Administrative Expense of $21.61 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- THE PENNANT GROUP, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $21.61M, a 22.83% increase year-over-year.
- THE PENNANT GROUP, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $19.69M, a 32.66% increase year-over-year.
- THE PENNANT GROUP, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $19.34M, a 39.45% increase year-over-year.
- THE PENNANT GROUP, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $19.30M, a 48.17% increase year-over-year.
- THE PENNANT GROUP, INC. selling, general and administrative expense for fiscal 2025 was $71.08M, a 41.56% increase from fiscal 2024.
- THE PENNANT GROUP, INC. selling, general and administrative expense for fiscal 2024 was $50.21M, a 36.93% increase from fiscal 2023.
- THE PENNANT GROUP, INC. selling, general and administrative expense for fiscal 2023 was $36.67M, a 7.90% increase from fiscal 2022.
- THE PENNANT GROUP, INC. selling, general and administrative expense for fiscal 2022 was $33.98M, a 6.28% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.61M 10-Q · filed 2026-08-05 | $41.30M 10-Q · filed 2026-08-05 | $60.65M derived: sum of 3 quarters · filed 2026-08-05 | $79.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $19.69M 10-Q · filed 2026-05-06 | $39.03M derived: sum of 2 quarters · filed 2026-05-06 | $58.33M derived: sum of 3 quarters · filed 2026-05-06 | $75.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $19.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.64M derived: sum of 2 quarters · filed 2026-02-26 | $56.24M derived: sum of 3 quarters · filed 2026-08-05 | $71.08M 10-K · filed 2026-02-26 |
| 2025-09-30 | $19.30M 10-Q · filed 2025-11-05 | $36.89M derived: sum of 2 quarters · filed 2026-08-05 | $51.73M 10-Q · filed 2025-11-05 | $65.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $17.60M 10-Q · filed 2026-08-05 | $32.44M 10-Q · filed 2026-08-05 | $46.31M derived: sum of 3 quarters · filed 2026-08-05 | $59.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $14.84M 10-Q · filed 2026-05-06 | $28.71M derived: sum of 2 quarters · filed 2026-05-06 | $41.73M derived: sum of 3 quarters · filed 2026-05-06 | $53.61M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $13.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.89M derived: sum of 2 quarters · filed 2026-02-26 | $38.77M derived: sum of 3 quarters · filed 2026-02-26 | $50.21M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.02M 10-Q · filed 2025-11-05 | $24.90M derived: sum of 2 quarters · filed 2025-11-05 | $36.34M 10-Q · filed 2025-11-05 | $46.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $11.88M 10-Q · filed 2025-08-06 | $23.31M 10-Q · filed 2025-08-06 | $33.07M derived: sum of 3 quarters · filed 2026-02-26 | $42.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $11.44M 10-Q · filed 2025-05-06 | $21.19M derived: sum of 2 quarters · filed 2026-02-26 | $30.61M derived: sum of 3 quarters · filed 2026-02-26 | $39.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.17M derived: sum of 2 quarters · filed 2026-02-26 | $27.96M derived: sum of 3 quarters · filed 2026-02-26 | $36.67M 10-K · filed 2026-02-26 |
| 2023-09-30 | $9.42M 10-Q · filed 2024-11-06 | $18.21M derived: sum of 2 quarters · filed 2024-11-06 | $26.91M 10-Q · filed 2024-11-06 | $35.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $8.79M 10-Q · filed 2024-08-06 | $17.50M 10-Q · filed 2024-08-06 | $25.82M derived: sum of 3 quarters · filed 2025-02-27 | $31.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $8.71M 10-Q · filed 2024-05-06 | $17.03M derived: sum of 2 quarters · filed 2025-02-27 | $22.91M derived: sum of 3 quarters · filed 2025-02-27 | $32.65M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $14.21M derived: sum of 2 quarters · filed 2025-02-27 | $23.95M derived: sum of 3 quarters · filed 2025-02-27 | $33.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | $5.88M 10-Q · filed 2023-11-07 | $15.62M derived: sum of 2 quarters · filed 2023-11-07 | $25.65M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $9.74M 10-Q · filed 2023-08-08 | $19.77M 10-Q · filed 2023-08-08 | ||
| 2021-12-31 | $36.26M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |